(USD) | Dec 2023 | Q/Q |
---|---|---|
Revenue | 30.6MM | +9% |
Gross Profit | 21.7MM | - |
Cost Of Revenue | 8.8MM | +25% |
Operating Income | -322K | -87% |
Operating Expenses | 22.1MM | - |
Net Income | -786K | -112% |
R&D | 8.7MM | -11% |
G&A | 12.5MM | -2% |
Amortization | 900K | -10% |
Interest Expense | 896K | +0% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
EDEN PRAIRIE, Minn., April 19, 2024--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, May 1.
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SurModics (SRDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...
SRDX, X, TELNY, INSP and MTAL have been added to the Zacks Rank #1 (Strong Buy) List on April 9, 2023.
Surmodics, Inc. ( NASDAQ:SRDX ), is not the largest company out there, but it saw significant share price movement...
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
Surmodics (NASDAQ:SRDX) has had a rough month with its share price down 8.9%. It is possible that the markets have...
EDEN PRAIRIE, Minn., February 27, 2024--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the following upcoming investor conferences:
Surmodics, Inc. ( NASDAQ:SRDX ) defied analyst predictions to release its quarterly results, which were ahead of market...